Target intelligence / Profile preview

Immune system via paracrine factors and cell-contact molecules

Molecular classification
Other
01

Overview

The term 'Immune system via paracrine factors and cell-contact molecules' describes a complex physiological mechanism of immunomodulation rather than a single molecular target. This process is most notably associated with Mesenchymal Stem Cells (MSCs), which regulate the activity of T cells, B cells, and natural killer cells through two distinct but complementary pathways (Gao et al., 2016, 'Mesenchymal stem cells: a new strategy for immunosuppression'). The paracrine component involves the secretion of soluble factors such as Interleukin-10 (IL-10), Transforming Growth Factor-beta (TGF-β), and Indoleamine 2,3-dioxygenase (IDO), which create a suppressive chemical environment (Kyurkchiev et al., 2014, 'Secretion of immunomodulatory factors by mesenchymal stem cells'). Simultaneously, cell-contact molecules like PD-L1 and Fas ligand (FasL) interact directly with receptors on immune cells to trigger inhibitory signaling or apoptosis (Wang et al., 2014, 'Mesenchymal stem cells: immunomodulatory mechanisms and clinical applications'). While these pathways are critical for treating conditions like Graft-versus-Host Disease (GvHD) and autoimmune disorders, the entry is considered 'incorrect' as a target because it encompasses an entire system of diverse proteins and interactions rather than a specific, druggable molecule.

Other names
MSC-mediated immunomodulationParacrine and juxtacrine immune regulationCell-mediated immune suppressionStem cell immunomodulatory secretome
02

Mechanism of action

Modulation of the immune microenvironment through the simultaneous secretion of soluble anti-inflammatory mediators (paracrine) and direct physical interaction between cell-surface ligands and immune cell receptors (juxtacrine).

03

Biological functions

Immune responseSignal transductionCell-cell communicationApoptosisCytokine production
04

Disease associations

InflammationAutoimmune diseaseGraft-versus-host diseaseCancerInfection
05

Safety considerations

Systemic immunosuppression leading to opportunistic infectionsPotential for tumor microenvironment enhancementCytokine release syndrome (CRS)Ectopic tissue formation from cell therapiesImmunogenicity of allogeneic cells
06

Interacting drugs

Remestemcel-L

3 more in the full profile.

07

Biomarkers

Interleukin-10 (IL-10) levelsIndoleamine 2,3-dioxygenase (IDO) activityProstaglandin E2 (PGE2) levelsT-cell proliferation ratePD-L1 expression

Beyond the preview

Go deeper on Immune system via paracrine factors and cell-contact molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system via paracrine factors and cell-contact molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call